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Background: Growth factor receptor-bound protein 14 (Grb14) is an adapter protein implicated in receptor tyrosine
kinase signaling. Grb14 knockout studies highlight both the positive and negative roles of Grb14 in receptor tyrosine
kinase signaling, in a tissue specific manner. Retinal cells are post-mitotic tissue, and insulin receptor (IR) activation is
essential for retinal neuron survival. Retinal cells express protein tyrosine phosphatase-1B (PTP1B), which dephosphorylates
IR and Grb14, a pseudosubstrate inhibitor of IR. This project asks the following major question: in retinal neurons, how
does the IR overcome inactivation by PTP1B and Grb14?
Results: Our previous studies suggest that ablation of Grb14 results in decreased IR activation, due to increased PTP1B
activity. Our research propounds that phosphorylation in the BPS region of Grb14 inhibits PTP1B activity, thereby
promoting IR activation. We propose a model in which phosphorylation of the BPS region of Grb14 is the key element in
promoting IR activation, and failure to undergo phosphorylation on Grb14 leads to both PTP1B and Grb14 exerting their
negative roles in IR. Consistent with this hypothesis, we found decreased phosphorylation of Grb14 in diabetic type 1
Ins2Akita mouse retinas. Decreased retinal IR activation has previously been reported in this mouse line.
Conclusions: Our results suggest that phosphorylation status of the BPS region of Grb14 determines the positive or
negative role it will play in IR signaling.
Keywords: Grb14, PTP1B, Shp2, SRC activation, Tyrosine phosphorylation, Insulin receptor, Tyrosine kinase signalingIntroduction
Growth factor receptor-bound protein 14 (Grb14) is an
adaptor protein that is known to interact with a number
of receptor tyrosine kinases and signaling molecules
[1,2]. Grb14 has an inhibitory effect on receptor tyrosine
kinase signaling and, in particular, on insulin receptor sig-
naling [3]. Consistent with these findings, a genome-wide
association study demonstrated that single nucleotide poly-
morphisms at Grb14 are strongly associated with reduced
insulin sensitivity in diabetic patients [4]. While there is
convincing evidence of a negative role of Grb14 in insulin
signaling [5,6], experiments with Grb14-/- animals have also* Correspondence: raju-rajala@ouhsc.edu
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stated.revealed positive effects of Grb14 on receptor tyrosine kin-
ase signaling, in a tissue specific manner [7,8].
We previously identified Grb14 in retinal tissues [9].
Interestingly, Grb14 undergoes a light-dependent intra-
cellular translocation within rod photoreceptor neurons
[8]. Light induces activation of the insulin receptor (IR) and
ablation of Grb14 results in the loss of light-dependent acti-
vation of the IR [8]. In photoreceptors, Grb14 undergoes
tyrosine phosphorylation by light-activated non-receptor
tyrosine kinase Src, and phosphorylated Grb14 (Grb14-P)
acts as a positive regulator of the IR by inhibiting PTP1B, a
negative regulator of the IR [10]. Very recently, we reported
that Grb14 modulates the activity of the rod cyclic nucleo-
tide gated channel (CNG), and perhaps cGMP-phospho
diesterase in regulating rod transduction and light adapta-
tion [11]. We also revealed that CNG channel phosphoryl-
ation is regulated by IR [12], while Grb14 regulates both
IR activation and CNG channel modulation [10,11,13].
A high expression of Grb14 in myocardial tissue activatestd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited. The Creative Commons Public Domain Dedication
ain/zero/1.0/) applies to the data made available in this article, unless otherwise
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cardial infarction and decreased PI3K/Akt activation [7]. In
several models of insulin resistance, increased expression
of Grb14 in adipose tissue has previously been reported
[14]. Convincing evidence for a negative role of Grb14 in
insulin signaling exists [15]. This evidence shows enhanced
glucose tolerance and insulin sensitivity in Grb14-deficient
mice [5]. Thus, our primary research question is how
Grb14 achieves negative or positive roles in IR signaling.
The molecular switch determining whether Grb14 will per-
form a particular role is unknown. Our studies suggest that
the phosphorylation status of Grb14 is the key element in
determining whether it will execute a negative or positive
role in IR signaling.Results
Effect of a phosphorylated BPS region of Grb14 on IR
kinase activity
To determine whether Grb14 phosphorylation performs
any role in IR kinase activity, we examined the effect of
non-phosphorylated and phosphorylated BPS regions of
Grb14 on IR kinase activity in vitro (Figure 1A). Non-
phosphorylated and phosphorylated BPS domains of GST-
Grb14 were expressed alone, or co-expressed with VSRC
and purified according to the method described earlier
[10]. Both inhibited the IR kinase activity equally well
(Figure 1B). The crystal structure of the BPS domain
revealed that a region between amino acids 373 and 381 is
involved in binding to the IR, and that Glu373 is crucial
for this binding [16].
The mutant GST-BPS-SH2 (E373Q) and wild-type
GST-BPS-SH2 Grb14 were either expressed alone or co-
expressed with VSRC [17]. The expressed proteins were
purified and immunoblotted with anti-PY99 antibody.
The results indicated that VSRC mediated phosphoryl-
ation of the BPS-SH2 (E373Q) and wild-type BPS-SH2
domains (Figure 1C). To ensure equal amounts of fusion
proteins, we reprobed the blot with anti-GST antibody
(Figure 1C).
Non-phosphorylated and phosphorylated BPS-SH2 (E3
73Q) domains of Grb14 were tested for their effect on
IR kinase activity. This mutant BPS region failed to in-
hibit the IR kinase activity, regardless of phosphorylation
status (Figure 1B). However, the same mutant was able
to inhibit PTP1B activity, similar to the wild-type BPS
region of Grb14, and the inhibition caused by the phos-
phorylated E373Q-BPS region was significantly greater
than that of the non-phosphorylated E373Q-BPS-SH2
domain (Figure 1D). These results show that phosphory-
lated and non-phosphorylated BPS domains equally in-
hibit IR kinase activity, whereas the phosphorylated BPS
domain significantly inhibits PTP1B activity to a greater
extent than its non-phosphorylated counterpart. Thesedata suggest that IR and PTP1B inhibitory activities are
influenced by the BPS region of Grb14.
Interaction of phosphorylated Grb14 with vSrc-SH2 domain
The Tyr347 residue in the BPS region of Grb14 is es-
sential for PTP1B binding and inhibition of its activity
[10]. The SH2 domain of the Src family recognizes the pre-
ferred sequence with the general motif pTyr-hydrophilic-
hydrophilic-Ile/Pro [18]. The phosphorylated Grb14 BPS
region has the sequence pTyr-Gln-Asn-Tyr followed by a
bulky side chain of Met, which is similar to the preferred
interacting sequences of the SH2 domain of Src. To in-
vestigate whether the SH2 domain of vSrc binds to the
phosphorylated BPS region, the expressed His-tagged BPS
region of Grb14, either alone or co-expressed with VSRC
in E. coli (Figure 2A), was subjected to a GST pull-down
assay with either GST or GST-vSrc-SH2 fusion proteins.
The bound proteins were immunoblotted with anti-His
antibody. The vSrc-SH2 domain associated with the BPS
region only under phosphorylated conditions (Figure 2B).
The blot was reprobed with anti-GST antibody to en-
sure equal amounts of fusion proteins in each pull-down
(Figure 2C-D).
We previously reported a light-dependent phosphoryl-
ation of Grb14 in vivo [10]. In this study, we examined
whether the vSrc-SH2 domain is able to bring down phos-
phorylated Grb14. We subjected the dark- and light-
adapted mouse retina lysates [19] of wild-type and Grb14-/-
mice (Figure 2H) to a GST-vSrc-SH2 pull-down assay. The
bound proteins underwent immunoblotting with anti-PY99
and anti-Grb14 antibodies (Figure 2E-F). To ensure equal
amounts of fusion proteins, we reprobed the blot with anti-
GST antibody (Figure 2G). The results revealed the pres-
ence of phosphorylation on Grb14 and its association with
the vSrc-SH2 domain, specifically in light-adapted wild-type
retinas, but not in dark-adapted wild-type retinas or in
dark- and light-adapted Grb14-/- mice (Figure 2E-F). These
data suggest that Grb14 undergoes light-dependent phos-
phorylation in the retina, and that the vSrc-SH2 domain is
able to associate with phosphorylated Grb14 in vitro. This
also indicates the specificity of the interaction between
Grb14 and the vSrc-SH2 domain in vitro.
We previously reported that Grb14 phosphorylation
was absent in the retinal pigment epithelium 65 knockout
(Rpe65-/-) mice [10]. Rpe65-/- mice have opsin in their
photoreceptor outer segments, but do not form photo-
bleachable rhodopsin (the activated form), due to the ab-
sence of regeneration of the chromophore 11-cis-retinal
[20]. To further confirm the specificity of the vSrc-SH2
domain with phosphorylated Grb14, we subjected the ret-
inal lysates of the wild-type and Rpe65-/- mice to GST-
vSrc-SH2 pull-down and immunoblotting with anti-PY99
(Figure 2I) and anti-Grb14 (Figure 2J) antibodies. To en-
sure equal amounts of fusion proteins in each pull-down,
Figure 1 Effect of a phosphorylated BPS region of Grb14 on IR kinase and PTP1B activity. The domain organization of Grb14 and length
of the BPS region is depicted (A). IR kinase activity was measured in the presence of either GST or GST-BPS-SH2 or mutant GST-BPS-SH2 (E373Q)
in both non-phosphorylated and phosphorylated states (B), immunoblot of expressed proteins with anti-PY99 antibody and the same blot
stripped and reprobed with anti-GST antibody (C). The fusion proteins (12 μM) that were used in the IR kinase activity (B) were further examined
for their effect on PTP1B activity (D). Data are mean ± S.D., n = 3, **p < 0.001; *p < 0.05, P-Phosphorylated.
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Loss of light-dependent phosphorylation of Grb14 oc-
curred in the Rpe65-/- mice, but Grb14 phosphorylation
occurred in the wild-type mice under light-adapted condi-
tions (Figure 2I). These results suggest that rhodopsin me-
diates the activation of Grb14 phosphorylation in vivo.
As shown in Figure 2 (panels L-N), we treated GST-
vSrc pull-downs of dark- and light-adapted rat retinal ly-
sates with calf-intestinal phosphatase (CIP) for 30 min
and then washed the bound fusion proteins twice in
wash buffer [21] prior to immunoblot analysis. The re-
sults indicate a loss of PY99 immunoreactivity and a lossof Grb14 association with vSrc-SH2 domain in CIP-treated
retinas compared to light-adapted CIP-untreated retinas
(Figure 2L-N). This experiment further confirms that
Grb14 undergoes tyrosine phosphorylation in vivo and that
phosphorylation is necessary for its association with the
vSrc-SH2 domain in vitro. The vSrc-SH2 domain could be
used as a tool to study the phosphorylation status of Grb14
in various tissues and cell types. Currently, there are
no species-specific Grb14 antibodies with which to per-
form immunoprecipitation. The described vSrc-SH2 pull-
down assay would be an excellent choice to study Grb
14 phosphorylation under physiological and pathological
Figure 2 Association of phosphorylated Grb14 with SH2 domain of vSrc in vitro. The His-tagged BPS domain of Grb14 was either expressed
or coexpressed with VSRC (A), and the proteins were incubated with GST or GST-vSrc-SH2 fusions followed by a GST pull-down assay. The bound
proteins were subjected to immunoblot analysis with the anti-His antibody (B) and reprobed with the anti-GST antibody (C, D). The dark- and
light-adapted retinal lysates from wild-type and Grb14-/- mice were subjected to a GST-vSrc-SH2 pull-down assay followed by immunoblotting
with anti-PY99 (E), anti-Grb14 (F), and anti-GST (G) antibodies. Wild-type and Grb14-/- mouse retinal lysates were immunoblotted for Grb14 with
anti-Grb14 antibody (H). Retinal lysates from dark- and light-adapted wild-type and Rpe65-/- mice were incubated with the GST-vSrc-SH2 fusion
protein followed by a GST pull-down assay. The bound proteins were subjected to immunoblotting with anti-PY99 (I) and anti-Grb14 (J) antibodies,
and reprobed with anti-GST antibody (K). Retinal lysates from dark- and light-adapted wild-type mice were incubated with the GST-vSrc-SH2 fusion
protein followed by GST pull-down assay. One set of the fusion was treated with calf-intestinal phosphatase for 30 min. The fusions were washed and
subjected to immunoblotting with anti-PY99 (L) and anti-Grb14 (M) antibodies, and reprobed with anti-GST antibody (N).
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mouse retinas provide a small amount of tissue material:
the pull-down assay would be of great advantage in study-
ing Grb14 phosphorylation. However, we failed to observe
an endogenous interaction between phosphorylated Grb14
and Src in mammalian cells (data not shown).Association of Src and Grb14 to light-adapted outer
segment membranes
We previously reported a light-induced tyrosine phos-
phorylation of Grb14 by non-receptor tyrosine kinase Src
[10]. Src activation has been shown to occur in photo-
receptor outer segments [22]. In our previous study, we
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sates. In this experiment, we examined the state of tyrosine
phosphorylation on Grb14 and Src in rod outer segments
(ROS) prepared from dark- and light-adapted rats. ROS
membranes were prepared from dark- (DROS) and light-
adapted (LROS) rats on a discontinuous sucrose density
gradient centrifugation. The adaptability of animals to dark
and light conditions was examined with rod arrestin and
rod transducin alpha (Tα) immunolocalization. In dark-
adapted retinas, arrestin is localized to the rod inner seg-
ments and the outer plexiform layer (Figure 3A), while
Tα is localized to rod outer segments (Figure 3A). Upon
light illumination, arrestin is translocated to photorecep-
tor outer segments, while Tα moves to rod inner segments
(Figure 3A).
Three independent preparations of DROS and LROS
proteins were subjected to immunoblot analysis with
Grb14, pTyr416-Src, Src, arrestin, Tα, and rhodopsin. The
results indicate that photoreceptor marker arrestin is en-
riched in LROS (Figure 3E), while Tα is enriched in DROS
(Figure 3F), further confirming the strict adaptability of rats
to dark- and light-adaptation. The integral membrane pro-
tein opsin expression remains the same between DROS
and LROS (Figure 3G). We found the association of both
Grb14 and Src with LROS, but not with DROS (Figure 3B
and D). The pTyr416-Src blot shows that LROS-associated
Src is tyrosine phosphorylated (Figure 3C).
To determine whether phosphorylation of Grb14 oc-
curs in LROS, we subjected the solubilized DROS and
LROS to a GST-vSrc-SH2 pull-down assay. The bound
proteins were immunoblotted with anti-PY99 and anti-
Grb14 antibodies (Figure 3H and 3I). To ensure equal
amounts of fusion proteins, we reprobed the blot with
anti-GST antibody (Figure 3J). The results revealed the
presence of phosphorylation on Grb14 and its associ-
ation with the vSrc-SH2 domain, specifically in LROS
(Figure 3H). These data suggest that Grb14 undergoes
light-dependent phosphorylation in the retina, and that
the vSrc-SH2 domain is able to associate with phosphor-
ylated Grb14 in vitro. These experiments suggest that
tyrosine phosphorylation of Src and Grb14 occurs in
outer segments upon light-adaptation.
Spatial and temporal regulation of IR activation and
interplay of PTP1B and Grb14
In support of our current findings, Figure 4 presents ag-
gregate data based on the results from our previous
studies of the IR kinase and PTP1B activities in wild-
type, PTP1B KO, and Grb14 KO mice [8,10,19]. Using
this data, we summarized the spatial and temporal regula-
tion of IR activation and interplay of PTP1B and Grb14
(Figure 4). We detected a light-dependent IR kinase activ-
ity in wild-type mice (Figure 4A). In the absence of PTP1B,
IR kinase activity in dark-adapted retinas was similar tothe IR kinase activity found in light-adapted wild-type
mouse retinas (Figure 4A). In Grb14−/− mice, the light-
dependent activation of IR kinase activity was lost and was
comparable to the dark-adapted retinal controls (Figure 4A).
Consistent with these observations, PTP1B activity was sig-
nificantly lower in the light-adapted retinas than in the
dark-adapted wild-type controls (Figure 4B). The loss of
light-dependent inhibition of PTP1B activity in Grb14-/-
mice demonstrates that Grb14 regulates light-dependent
PTP1B activity (Figure 4B). These results suggest that IR
activation is mediated through PTP1B inhibition via Grb14.
Grb14 phosphorylation is specific to retina
We isolated retinal, heart, and liver tissues from dark-
and light-adapted rats, and the respective lysates were
incubated with vSrc-SH2 fusion followed by a GST pull-
down assay. The bound proteins were subjected to im-
munoblotting with anti-Grb14 antibody (Figure 5A) and
the blot was reprobed with anti-GST antibody (Figure 5C).
Tissue lysates also underwent immunoblot analysis with
anti-Grb14 antibody, to examine the expression of Grb14
in all of the tissues. Even though Grb14 was expressed in
all tissues (Figure 5B), the phosphorylation of Grb14 was
exclusively observed in retinal tissue under light-adapted
conditions (Figure 5A).
Decreased Grb14 phosphorylation in type 1 diabetic
mouse retina
In this study, we examined the phosphorylation status of
Grb14 in type 1 diabetic Ins2Akita mice. The Ins2Akita
mutation results in a single amino acid substitution in
the insulin 2 gene that causes misfolding of the insulin
protein [23]. Male mice heterozygous for this mutation
have progressive loss of beta-cell function, decreased pan-
creatic beta-cell density, and significant hyperglycemia as
early as 4 weeks of age [23]. The mean blood glucose
levels of control and Ins2Akita mice are shown in Figure 5D.
We considered mice with blood glucose levels higher than
250 mg/dL to be hyperglycemic. Control and Ins2Akita
mouse retinal lysates underwent GST pull-down assays
with the vSrc-SH2 domain, followed by immunoblot ana-
lysis with anti-Grb14 antibody (Figure 5E). The blot was
reprobed with anti-GST antibody (Figure 5F). The results
indicate a reduced binding of Grb14 with the vSrc-SH2
domain in Ins2Akita mouse retinas compared to controls
(Figure 5G), suggesting that Grb14 phosphorylation is re-
duced in type 1 diabetic mouse retinas.
Discussion
Our experiments show that the phosphorylation status of
Grb14 is the key element in determining whether it will
execute a negative or positive role in IR signaling. We
found no significant difference in the inhibition of IR kinase
activity when we compared phosphorylated and non-
Figure 3 Association of Grb14 and Src to light-adapted rod outer segment membranes. Immunofluorescence analysis with anti-transducin
(Tα) and anti-arrestin antibody was performed with dark- and light-adapted (300 lux for 30 min) rat retinal sections (A). The images are of the
same section viewed with a filter to detect transducin α (green), arrestin (red), and DAPI stained nuclei (blue). ROS, rod outer segment; RIS, rod
inner segment; ONL, outer nuclear layer; OPL, outer plexiform layer. ROS membranes were prepared from dark- and light-adapted rats on a
discontinuous sucrose density gradient centrifugation. DROS and LROS proteins were subjected to immunoblot analysis with anti-Grb14 (B),
anti-pTyr416-Src (C), anti-Src (D), anti-arrestin (E), anti-transducin-α (F), and anti-rhodopsin (G) antibodies. Solubilized DROS and LROS proteins
were incubated with the GST-vSrc-SH2 fusion protein for 2 h followed by GST pull-down assay. The bound proteins were subjected to
immunoblot analysis with anti-PY99 (H), anti-Grb14 (I), and anti-GST (J) antibodies.
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However, phosphorylated Grb14 produced greater inhib-
ition of PTP1B activity than its non-phosphorylated form
(Figure 1D). We also established that Grb14 undergoes a
light-dependent tyrosine phosphorylation in vivo, through
light-dependent activation of a non-receptor tyrosine kinase
Src. The mechanism of light-dependent activation of Src isnot known. However, it has previously been shown that Src
associates with bleached opsin [22]. Src-homology phos-
photyrosyl phosphatase 2 (Shp2) is known to regulate the
Src family kinases by dephosphorylating Tyr-527 on the
C-terminus of Src, thereby activating it [24]. Shp2 is
expressed in photoreceptors [25]. Additionally, we found a
light-dependent activation of Shp2 in the retina (data not
Figure 4 Regulation of IR activation through PTP1B and Grb14.
In support of our current findings, Figure 4 presents aggregate data
based on the results from our previous studies of the IR kinase and
PTP1B activities in wild-type, PTP1B KO, and Grb14 KO mice [8,10,19].
The IR immunoprecipitates from dark- and light-adapted wild-type,
PTP1B-/-, and Grb14-/- mice were subjected to IR kinase activity employing
poly Glu:Tyr peptide as a substrate (A). PTP1B activity was measured in
retinas harvested from the dark- and light-adapted wild-type and
Grb14-/- mice (B). Data are mean ± SD, n = 5, *p < 0.05. The IR kinase
activity and PTP1B activity in dark-adapted retinas was set at 100%.
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this intriguing phenomenon.
Our previous studies suggest that PTP1B resides in
rod outer segment membranes, and dephosphorylates
the IR in dark-adapted retinas, thus inactivating the IR
[19]. Grb14 is localized to rod inner segments in dark-
adapted retinas [8]. Following photon capture by rhod-
opsin, Grb14 moves to rod outer segments, where it is
tyrosine phosphorylated by light-activated Src and binds
to PTP1B: binding inhibits PTP1B phosphatase activity
and thus activates the IR [10].
Results from our earlier research also showed that ab-
lation of Grb14 increases PTP1B activity, which results
in decreased IR activation [8,10]. Based on our previous
data and the results of the current study, we propose a
model explaining how Grb14 performs a negative orpositive role in IR signaling (Figure 6). In tissues in
which Grb14 does not undergo phosphorylation, Grb14
can directly interact with the IR and acts as a negative
regulator. In tissues in which Grb14 undergoes tyrosine
phosphorylation, Grb14 binds to PTP1B and inhibits its
activity, thereby promoting IR signaling. In the event of
the loss of phosphorylation, the non-phosphorylated
form of Grb14 can act as a negative regulator and down-
regulate IR signaling. Consistent with this hypothesis, we
found decreased phosphorylation of Grb14 in diabetic
type 1 Ins2Akita mouse retinas (Figure 5E-G). Decreased
retinal IR activation has previously been reported in this
mouse line [26]. Also, decreased IR kinase activity in ret-
inal cells has been reported in experimental and genetic
models of type 1 diabetes [26,27]. The decreased IR acti-
vation is due to increased retinal PTP1B activity [27]. In
Rpe65-/- mice, a mouse model for defective rhodopsin
activation [20], the lack of phosphorylation of Grb14
also enhanced PTP1B activity [10,19]. These studies sug-
gest that decreased IR kinase activity [26] could be due
to a defect in the phosphorylation of Grb14. In sum-
mary, our results suggest that the phosphorylation status
of the BPS region of Grb14 determines whether Grb14
plays a positive or negative role in IR signaling. Further,
activators of Grb14 phosphorylation may have thera-
peutic potential in protecting the dying retinal neurons
in retinal degenerative diseases.
Materials and methods
PTP1B substrate RRLIEDAEPYAARG and the phosphat-
ase assay reagents were obtained from Upstate Biotech-
nology (Lake Placid, NY). The monoclonal PY99 antibody
was procured from Santa Cruz Biotechnology (Santa Cruz,
CA). A quick-change, site-directed mutagenesis kit was
purchased from Stratagene (La Jolla, CA). Anti-His, anti-
Src, and anti-Phospho Src (pTyr 416) antibodies were
acquired from Cell Signaling Technology, Inc. (Beverly,
MA). Anti-glutathione S-transferase (GST) antibody and
glutathione-Sepharose 4B matrix were obtained from
Amersham Biosciences Corp. (Piscataway, NJ). Human
recombinant-insulin receptor kinase-GST fusion was ac-
quired from Calbiochem (San Diego, CA). [γ32 P] ATP
was purchased from New England Nuclear (Boston, MA).
Generation of a polyclonal Grb14 antibody was described
earlier [8]. All other reagents were of analytical grade from
Sigma (St. Louis, MO).
Animals
All animal work was performed in strict accordance with
the Association for Research in Vision and Ophthalmol-
ogy’s statement on the “Use of Animals in Ophthalmic
and Vision Research”. All protocols were approved by
the Institutional Animal Care and Use Committee of the
University of Oklahoma Health Sciences Center and the
Figure 5 Tissue specific phosphorylation of Grb14. Retinal, heart, and liver protein lysates from dark- and light-adapted rats were incubated
with the GST-vSrc-SH2 fusion protein, followed by GST pull-down assay. The bound proteins were subjected to immunoblotting with anti-Grb14
(A) and anti-GST (C) antibodies. Tissue lysates underwent immunoblot analysis with anti-Grb14 antibody (B). Blood was drawn from control and
Ins2Akita mouse tail veins, and the blood glucose levels were monitored with a glucometer (D). Data are mean ± SE, n = 8, *p < 0.001. Control and
Ins2Akita mouse retinal lysates were subjected to GST-vSrc-SH2 fusion protein, followed by GST pull-down assay. The bound proteins were
subjected to immunoblot analysis with anti-Grb14 (E) and anti-GST (F) antibodies. Densitometric analysis of 4 independent immunoblots of
Grb14 was performed in the linear range of detection and absolute values were then normalized to v-Src-SH2 (G). Values are mean ± SEM, (n = 4),
*p < 0.05. The binding of Grb14 to the v-Src-SH2 domain in control mice was set at 100 percent.
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Sprague-Dawley (SD) rats is maintained in our vivarium
in cyclic light (5 lux; 12 h on/12 h off). Experiments were
carried out on both male and female rats (150–200 g).
Grb14-/- mice were kindly provided by Dr. Roger J Daly
(Garvan Medical Institute, Sydney, Australia) and Rpe65-/-
mice were provided by Dr. Jian-Xing Ma (University of
Oklahoma, USA). The generation of rod specific PTP1BFigure 6 Activation of IR signaling in the retinal neurons. IR is inactivated
kinase activity by Grb14 (A). Src kinase phosphorylates Grb14 (B), which trigg
inhibits the phosphatase activity (D). The IR, free from Grb14 and PTP1B, thus
receptor; PTP1B, protein tyrosine phosphatase 1B; Grb14, growth factor recepknockout animals has been reported previously [19]. C57
BL/6J Ins2Akita heterozygote mice (Jackson Laboratory,
Bar Harbor, ME) were bred in the Dean A. McGee Eye In-
stitute animal vivarium. Diabetic phenotype and genotype
were confirmed 4.5 weeks after birth by blood glucose >250
mg/dL (TrueTrack Smart System; AR-MED Ltd, Egham,
UK) in a drop of blood from a tail puncture. The disease is
100% penetrant in mice with the Ins2 mutation [28].through dephosphorylation by PTP1B and a direct inhibition of IR
ers the affinity switch from IR towards PTP1B, where it binds and directly
regulates the downstream neuron survival pathway (C). IR, insulin
tor-bound protein 14; P, phosphorylation; Pi, inorganic phosphate.
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The phosphorylation reaction was performed essentially
as described [8] in a total volume of 25 μL of 50 mM
Tris-HCl buffer (pH 7.0), 50 mM MgCl2, 5 mM MnCl2,
50 mM Na3VO4, 7 μg/mL p-nitrophenyl phosphate, 3
mg/mL poly Glu:Tyr peptide, IR cytoplasmic domain (1
μg), and Grb14 BPS fusion protein (either phosphory-
lated or non-phosphorylated). The reaction was initiated
by adding 2.5 μL [γ32P] ATP to reach a final concentration
of 200 μM, and the reaction was terminated by adding 10
μL of 50% (v/v) acetic acid. Twenty-five microliters of assay
mixture was spotted onto P81 phosphocellulose filter paper
disks (1.5 cm × 1.5 cm), which were immersed in a solution
containing 0.75% phosphoric acid (v/v). The filter paper
disks containing the bound phosphorylated peptide were
washed three times with phosphoric acid and rinsed in
acetone. Radioactivity was quantified in 5 mL of liquid scin-
tillation cocktail and counted (Ready Safe Liquid Scintilla-
tion Cocktail and Liquid Scintillation Counter, Beckman,
Fullerton, CA).PTP1B activity assay
The in vitro PTP1B activity assay was conducted based
on a previously published protocol using the peptide
RRLIEDAEPYAARG (Upstate Biotechnology) [10]. The
reaction was carried out in 60 μL volume in PTP assay
buffer [100 mm HEPES (pH 7.6), 2 mM EDTA, 1 mm
dithiothreitol, 150 mm NaCl, and 0.5 mg/ml bovine serum
albumin] at 30°C. At the end of the reaction, 40 μL aliquots
were placed into a 96-well plate, 100 μL of Malachite
Green Phosphatase reagent (Upstate Biotechnology) were
added, and absorbance was measured at 630 nm.Plasmid constructs
The amino acid sequences corresponding to the BPS re-
gion of Grb14 (amino acids 342 − 438) and the BPS-SH2
(amino acids 342 − 540) region were amplified by poly-
merase chain reaction (PCR) and cloned into pGEX-4T-
1 GST fusion vector. The BPS region of Grb14 was also
cloned into pTrcHisA vector. Cloning and expression of
retinal PTP1B was described earlier [27]. The SH2 re-
gion (amino acids 151-250) of VSRC was amplified with
sense, GGA TCC GGG AAG ATC ACT CGT CGG
GAG TCC, antisense, GAA TTC CTA GGG CTT GGA
CGT GGG GCA GAC, primers. After sequencing, the
fragment was excised as BamHI/EcoRI fragment and li-
gated into pGEX-2TK vector. The sequence of each
clone was verified by DNA sequencing. All inductions
yielded proteins of the expected size as determined by
Coomassie staining. The phosphorylation of each fusion
protein in E. coli (BL21) was achieved by coexpressing a
tyrosine kinase VSRC under the control of different repli-
cons [17]. The phosphorylated and non-phosphorylatedGST fusion proteins were purified using glutathione-
Sepharose beads.
Site-directed mutagenesis
Site-directed mutagenesis (SDM) was carried out accord-
ing to the method described earlier [29]. The reaction
mixture contained SDM buffer [200 mM Tris-HCl (pH
8.8), 100 mM KCl, 100 mM (NH4)2SO4, 20 mM MgSO4,
1% Triton X-100, 1 mg/ml nuclease-free bovine serum al-
bumin, 1 mM deoxynucleotide mix (dATP, dCTP, dTTP,
and dGTP)], 50 ng of vector, BPS-SH2 (R466A), and 125
ng of sense and antisense primers with mutations in a
total volume of 50 μl, followed by the addition of 2.5 units
of pfu DNA polymerase. The primers used in the site-
directed mutagenesis are as follows: E373Q (sense, AGA
AGT ATA TCA CAG AAT TCC CTG GTA GCA; anti-
sense, TGC TAC CAG GGA ATT CTG TGA TAT ACT
TCT). The sequence of each mutation was verified by
DNA sequencing. The phosphorylation of each fusion
protein in E. coli (BL21) was achieved by coexpressing a
tyrosine kinase VSRC under the control of different repli-
cons [17]. The phosphorylated and non-phosphorylated
GST fusion proteins were purified using glutathione-
Sepharose beads.
GST pull-down assays
Pull-down experiments were carried out as described
using GST fusion proteins that had been adsorbed onto
a glutathione − Sepharose 4B matrix. Retinal lysates were
incubated overnight with either GST or GST fusion pro-
teins at 4°C with continuous stirring. The Sepharose beads
were washed three times in 500 μL of PBS and centrifuged
at 5000 rpm for 30 − 60 s at 4°C. Bound proteins were
eluted by boiling in 2X SDS sample buffer for 5 min be-
fore separating using 10% SDS − PAGE. The gels were
then subjected to immunoblot analysis with appropriate
antibodies.
Preparation of rat rod outer segments
Rod outer segments (ROS) were prepared from rat retinas
using a discontinuous sucrose gradient centrifugation as
previously described [30]. Retinas were homogenized in
4.0 ml of ice-cold 47% sucrose solution containing 100
mM NaCl, 1 mM EDTA, 1mM NaVO3, 1 mM PMSF, and
10 mM Tris-HCl (pH 7.4) (buffer A). Retinal homogenates
were transferred to 15-ml centrifuge tubes and sequen-
tially overlaid with 3.0 ml of 42%, 3.0 ml of 37%, and 4.0
ml of 32% sucrose dissolved in buffer A. The gradients
were spun at 82,000 × g for 1 h at 4°C. The 32/37% in-
terfacial sucrose band containing ROS membranes was
harvested and diluted with 10 mM Tris-HCl (pH 7.4) con-
taining 100 mM NaCl and 1 mM EDTA, and centrifuged
at 27,000 × g for 30 min. The ROS pellets were resus-
pended in 10 mM Tris-HCl (pH 7.4) containing 100 mM
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concentrations were determined by the BCA reagent fol-
lowing the manufacturer’s instructions.
SDS-page and immunoblotting
Proteins were resolved by 10% SDS-PAGE and transferred
to nitrocellulose membranes. The blots were washed twice
for 10 min with TTBS [20 mM Tris-HCl (pH 7.4), 100
mM NaCl, and 0.1% Tween-20] and blocked with either
5% bovine serum albumin or non-fat dry milk powder
(Bio-Rad) in TTBS for 1 h at room temperature. Blots were
then incubated with anti-Grb14 (1:1000), anti-pTyr-416-
Src (1:1000), anti-Src (1:1000), anti-His (1:1000), anti-PY99
(1:1000), anti-arrestin (1:1000), anti-Tα (1:1000), at 4°C
overnight or anti-GST (1:5000), anti-opsin (1:10,000) for 1
h at room temperature. Following primary antibody incu-
bations, immunoblots were incubated with HRP-linked
secondary antibodies (mouse or rabbit) and developed by
enhanced chemiluminescence according to the manufac-
turer’s instructions.
Statistical methods
Data were analyzed and graphed using GraphPad Prism
software (GraphPad Software, San Diego, CA). The data
were expressed as the mean ± S.E. and compared by
Student's t test for unpaired data. The significance level
was set at p < 0.05 or p < 0.001.
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